It has been shown previously that lipophilic (lipid soluble) drugs administered in lipid-based formulations (or using lipophilic prodrugs) can be delivered in very high concentrations to the intestinal lymphatics. In order for the intestinal lymphatic targeting to be clinically relevant, the response of intestinal lymph following oral administration of lipids needs to be investigated in humans. This is the first study we are aware of using MRI to study changes in lymph nodes following the consumption of a fatty meal. With optimisation this method could provide a novel marker of which nodes could be target for treatment using lipophilic drugs.
This abstract and the presentation materials are available to members only; a login is required.